Leo Giancola lost his mom Ivette Giancola to neuroendocrine cancer when he was still in kindergarten. While his memories of her at that age are
When we launched Breakthroughs Today, Cures Tomorrow, we made a promise: to accelerate the science that leads to better treatments and, ultimately, cures for neuroendocrine
More than 1,100 patients and caregivers from across the United States and internationally participated in NETRF’s 2026 Annual Patient and Caregiver Survey, sharing their experiences,
By Anna C. Greene, PhD, NETRF Chief Scientific Officer Two recent NETRF-funded studies are offering new insight into how neuroendocrine tumors grow, spread, and respond
At the Neuroendocrine Tumor Research Foundation (NETRF), we support research that can move the field forward, not only by advancing new treatments, but also by
By Anna C. Greene, PhD, NETRF Chief Scientific Officer A new multi-institutional study provides one of the most comprehensive pictures to date of what life
Tijana Jovanovic-Talisman, PhD, is an Associate Professor at Beckman Research Institute at City of Hope and a 2025 NETRF Pilot Award grantee for her research
For many families affected by neuroendocrine cancer, supporting research becomes a deeply personal mission. For Wayne Firsty and his children, Shay and Alana, that commitment
Clinical Trials Highlight Advances in Neuroendocrine Tumor Research Research into neuroendocrine tumors (NETs) continues to progress, with clinical trials exploring both new treatment approaches and
More than one thousand neuroendocrine cancer researchers, physicians, and patient advocates from over 50 countries gathered this month in Krakow, Poland, for the 23rd Annual